In recent weeks, the IPO market has seen newly public companies stumbling into a harsh investor climate due to market fears surrounding economic slowdowns and trade uncertainties. The market rallies of last week seemed to have increased investor confidence in new companies, with the latest public companies trading modestly in their first few days.
Recently Priced:
Oyster Point Pharma, Inc. (NASDAQ: OYST) entered on the market on October 31 at the lower end of its shares at $16. The biotech company had raised an offering amount of $80 million and had 5 million initial shares. In the company's first day of trading, it opened slightly above its IPO pricing and closed at $18.48. The stock in its first week has slightly lost its gains, but it is currently trading in the $18 range.
Rapt Therapeutics, Inc. (NASDAQ: RAPT) also priced on October 31 offering 3 million shares and an amount of $36 million. The biopharmaceutical company's stock price was initially $12 per share. In the stock's first day, it opened a couple cents above its IPO pricing and has continued a steady increase into its announce closing on November 4.
FangDD Network Group LTD. (NASDAQ: DUO) priced at $13 per share on November 1. With and offering amount of $78 million and 6 million shares, the Chinese based property technology company opened slightly above their initial pricing, but have continued to decline in its first week of trading.
FinServ Acquisition Corp. (NASDAQ: FSRVU) also debuted on the public market on November 1, pricing at $10 per share. With an offering amount of $220 million and 22 million shares raised, the black check company continues to make small gains in its first couple days of trading.
Osprey Technology Acquisition Corp. (NYSE: SFTW.U) opened for public trading on November 1, with the technology-focused special purpose acquisition firm raising $257 million from 27.5 shares. The IPO priced at $10 and continues to trade at that price.
Upcoming:
Q&K International Group LTD. is set to trade globally on the Nasdaq November 5. The stock price is estimated to be between $17-$19. The Chinese real estate company has an offering amount of $58,995,000 and 2.7 million raised shares.
89Bio, Inc. is set to debut on November 6 to trade on the global Nasdaq with a stock price between $15-$17. The biotechnology company has an offering amount of $85,531,250 and currently 4,375,000 shares.
36KR Holdings Inc. is set to debut on the global Nasdaq November 7 with a stock price between $14.50-$17.50. The Chinese fundraising start-up has raised an offering of $72,450,000 and currently has 3.6 million shares.
Centogene B.V. is set to trade on the global Nasdaq also on November 7 with share prices between $14-$16. The company focused on rare diseases has a public offering amount of $73.6 million and 4 million shares.
Galera Therapeutics, Inc. also set to trade globally on the Nasdaq on November 7 with share prices pricing between $14-$15. The biopharmaceutical firm currently had 5 million shares and $92 million raised for public offering.
GFL Environmental Holdings, Inc. on November 7 on the New York Stock Exchange. With stock prices in the range of $20-$24 and 87,572,500 shares, North America's fourth-biggest waste hauler has raised a large offering amount of $2,417,001,000.
Silvergate Capital Corp. is also set to debut on the New York Stock Exchange with a range of $13-$15 on November 7. The bank has raised 4,305,952 shares and an offering amount of $64,589,280.
CNS Pharmaceuticals, Inc. debuting on November 8 with a stock price set between $4-$5. Set to trade on the Nasdaq, the pharmaceutical company has raised 2,125,000 shares and an offering amount of $12,218,750.
Tela Bio, Inc. is also slated to trade globally on the Nasdaq on November 8. The biotechnology company is set to have shares pricing between $14-$16. The company has 4 million shares and and offering amount of $73.6 million.
Filings
Alussa Energy Acquisition Corp. filed on November 1 with an offering amount of $258,750,000.
Withdrawn
Hoverink Biotechnologies, Inc. filed on December 20, 2018 and withdrew on October 31.